Ilknur Kivanc Altunay

Ilknur Kivanc Altunay

Auto-generated profile, based on publicly available information

Ilknur Kivanc Altunay

University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital, Dermatology Department

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Open access
FDFlorence J. Dalgard
Florence J. Dalgard
ÅSÅke Svensson
Åke Svensson
JHJon Anders Halvorsen
Jon Anders Halvorsen
UGUwe Gieler
Uwe Gieler
CSChristina Schut
Christina Schut
JKJörg Kupfer
Jörg Kupfer
Itch is a highly prevalent and multidimensional symptom. We aimed to analyze the association between itch and mental health in dermatological patients. This multicenter study is observational and cross-sectional and was conducted in dermatological clinics across 13 European countries. A total of 3,530 patients and 1,094 healthy controls were included. Patients were examined clinically. Outcome measures were itch (presence, chronicity, and intensity), the Hospital Anxiety and Depression Scale, EQ-5D visual analogue scale, sociodemographics, suicidal ideation, and stress (negative life events and economic difficulties). Ethical approval was obtained. Results showed significant association between the presence of itch in patients and clinical depression (odds ratio, 1.53; 95% confidence interval, 1.15-2.02), suicidal ideation (odds ratio, 1.27; 95% confidence interval, 1.01-1.60), and economic difficulties (odds ratio, 1.24; 95% confidence interval, 1.10-1.50). The mean score of reported generic health status assessed by the EQ-5D visual analogue scale was 65.9 (standard deviation = 20.1) in patients with itch, compared with 74.7 (standard deviation = 18.0) in patients without itch (P < 0.001) and 74.9 (standard deviation = 15.7) in controls with itch compared with 82.9 (standard deviation = 15.6) in controls without itch (P < 0.001). Itch contributes substantially to the psychological disease burden in dermatological patients, and the management of patients should include access to multidisciplinary care.

18 January 2022 in British Journal of Dermatology
Verified
Journal Article
Open access
PDF file
CSChristina Schut
Christina Schut
FDFlorence J. Dalgard
Florence J. Dalgard
ABAnthony Bewley
Anthony Bewley
AEAndrea W.M. Evers
Andrea W.M. Evers
UGUwe Gieler
Uwe Gieler
TCthe ESDAP Study collaborators
the ESDAP Study collaborators
Background Body dysmorphic disorder (BDD) is a common psychiatric disorder associated with high costs for healthcare systems as patients may repeatedly ask for different, often not effective interventions. BDD symptoms are more prevalent in patients with dermatological conditions than the general population, but there are no large sample studies comparing the prevalence of BDD symptoms between patients with dermatological conditions and healthy skin controls. Objectives To compare the prevalence of BDD symptoms between patients with different dermatological conditions and healthy skin controls and to describe sociodemographic, physical and psychological factors associated with BDD symptoms to identify patients who may have a particularly high chance of having this condition. Methods This observational cross-sectional, comparative multi-centre study included 8295 participants: 5487 consecutive patients with different skin diseases (56% female) recruited among dermatological out-patients at 22 clinics in 17 European countries and 2808 healthy skin controls (66% female). All patients were examined by a dermatologist. BDD symptoms were assessed by the Dysmorphic Concern Questionnaire (DCQ). Sociodemographic data, information on psychological factors and physical conditions were collected. Each patient was given a dermatological diagnosis according to ICD-10 by a dermatologist. Results The participation rate of invited dermatological patients was 82.4% on average across all centres. BDD symptoms were five times more prevalent in patients with dermatological conditions than in healthy skin controls (10.5% vs. 2.1%). Patients with hyperhidrosis, alopecia and vitiligo had a more than eleven-fold increased chance (adjusted Odds Ratio (OR) > 11) of having BDD symptoms compared to healthy skin controls, and patients with atopic dermatitis, psoriasis, acne, hidradenitis suppurativa, prurigo and bullous diseases had a more than six-fold increased chance (adjusted OR > 6) of having BDD symptoms. Using a logistic regression model, BDD symptoms were significantly related to lower age, female sex, higher psychological stress and feelings of stigmatisation. Conclusions This study reveals that clinical BDD symptoms are significantly associated with common dermatological diseases. As such symptoms are associated with higher levels of psychological distress and multiple unhelpful consultations, general practitioners and dermatologists should consider BDD and refer patients when identified to an appropriate service for BDD screening and management.

7 June 2020 in Contact Dermatitis
Verified
Journal Article
Open access
PDF file
YEYasemin Erdem
Yasemin Erdem
IAIlknur Kivanc Altunay
Ilknur Kivanc Altunay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
SISena Inal
Sena Inal
EUEce Ugurer
Ece Ugurer
EÖEsen Özkaya
Esen Özkaya
Click on the article title to read more.

1 January 2019 in Annals of Dermatology
Verified
Journal Article
Open access
EKEzgi Aktaş Karabay
Ezgi Aktaş Karabay
AÇAslı Aksu Çerman
Aslı Aksu Çerman
DDDamla Demir
Damla Demir
IAIlknur Kıvanç Altunay
Ilknur Kıvanç Altunay
Currently, no generally accepted laboratory marker for monitorizing the disease activity and therapy response of psoriasis is known. The aim of the study is to evaluate the effects of systemic therapies on C-reactive protein (CRP) and the neutrophil-lymphocyte ratio (NLR) in psoriasis. One hundred patients with psoriasis treated with narrow band ultraviolet B, acitretin, cyclosporine, methotrexate, adalimumab, etanercept, and ustekinumab were prospectively evaluated. At baseline and at week 12, CRP, NLR, and Psoriasis Area and Severity Index (PASI) were evaluated. A statistically significant decrease was observed in PASI scores, CRP, and NLR values from the baseline to the 12-week visit (p=0.001, p=0.001, p=0.001, respectively). The reduction in PASI scores and NLR values was positively correlated (r=0.460, p=0.001). The comparisons between treatment groups revealed that the median decrease in NLR values was statistically higher in the adalimumab group than in the methotrexate group (p=0.007). And the median decrease in PASI scores was significantly higher in the adalimumab group compared with the methotrexate and acitretin therapy group (p=0.007, p=0.042, respectively). In the present study, systemic therapy of psoriasis was demonstrated to decrease the levels of CRP and NLR, which are known to be indicators of systemic inflammation and cardiovascular comorbidities.

1 November 2020 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
EÖEzgi Özkur
Ezgi Özkur
YEYasemin Erdem
Yasemin Erdem
IAİlKnur Kıvanç Altunay
İlKnur Kıvanç Altunay
DDDamla Demir
Damla Demir
NDNurcihan Çalışkan Dolu
Nurcihan Çalışkan Dolu
AÇAslı Aksu Çerman
Aslı Aksu Çerman
Hidradenitis suppurativa is a chronic inflammatory skin disease of terminal follicular acroinfundibulum. This study aimed to evaluate serum irisin, plasma glucose, insulin, and lipid levels in hidradenitis suppurativa, and elucidate possible associations with disease activity, inflammatory, or metabolic parameters. This case-control study included 37 patients (M/F: 9/28) and 37 sex-, age- and body mass index -matched healthy controls (M/F: 11/26). Demographic data, Hurley stage of disease, fasting glucose, insulin, total cholesterol, high density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, C-reactive protein levels, erythrocyte sedimentation rate, hematologic parameters, and serum irisin were assessed. The hidradenitis suppurativa group had significantly higher waist circumference than controls (p<0.001). Insulin resistance, defined as a homeostatic model assessment for insulin resistance value greater than 2.5, was observed in 45.9% of patients and 8.1% of controls (p=0.003), whereas metabolic syndrome was observed in 32.4% of patients and 5.4% of controls (p<0.001). Furthermore, plasma triglycerids, glucose, and insulin levels were significantly higher in the hidradenitis suppurativa (p=0.013, p=0.001, and p=0.004), respectively. Mean irisin level was insignificantly higher in the hidradenitis suppurativa group (37.4±32.6) than in controls (26.2±24.7, p=0.217). Physical activity and the exercise levels of participants were not documented. This study indicates that hidradenitis suppurativa patients have higher serum irisin, fasting plasma glucose, insulin, and triglycerides levels than healthy controls. Thus, the authors suggest that hidradenitis suppurativa patients should be evaluated for insulin resistance and metabolic syndrome, and monitored accordingly.

13 April 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
APA. Kara Polat
A. Kara Polat
EAE. Alpsoy
E. Alpsoy
GKG. Kalkan
G. Kalkan
SAS. Aytekin
S. Aytekin
DUD. Uçmak
D. Uçmak
AAA. Ataseven
A. Ataseven